Skip to main content
. 2009 Sep 1;94(1):74–79. doi: 10.1136/bjo.2009.158071

Table 5.

Treatment-related adverse events

Adverse event No (%) of patients
Bimatoprost (n = 131) Travoprost (n = 133)
Eye pruritus 3 (2.3%) 1 (0.8%)
Conjunctival or ocular hyperaemia 4 (3.1%) 2 (1.5%)
Punctate keratitis 1 (0.8%) 2 (1.5%)
Eye irritation 2 (1.5%) 0 (0.0%)
Growth of eyelashes 2 (1.5%) 0 (0.0%)
Abnormal sensation in eye 1 (0.8%) 0 (0.0%)
Drug hypersensitivity 0 (0.0%) 1 (0.8%)
Dry skin 1 (0.8%) 0 (0.0%)
Foreign-body sensation 0 (0.0%) 1 (0.8%)
Hyperaemia (non-ocular) 0 (0.0%) 1 (0.8%)
Pruritus at instillation site 0 (0.0%) 1 (0.8%)
Skin pigmentation 1 (0.8%) 0 (0.0%)
Visual acuity reduced 0 (0.0%) 1 (0.8%)
Overall* 11 (8.4%) 8 (6.0%)

*Patients reporting any treatment-related adverse event.